相关实验视频

Updated: Jul 5, 2025

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

结眼膜的转录基因分析对照在治疗眼的眼睛与干眼和健康的对照进行比较

Elena Carnero^1,2, Cristina Irigoyen-Bañegil¹, Itziar Gutiérrez¹

¹Department of Ophthalmology, Clínica Universidad de Navarra, University of Navarra, 31008 Pamplona, Navarra, Spain.

|January 23, 2024

概括

局部治疗青光眼的药物可能会导致眼睛表面疾病 (OSD). 这项研究发现,青光眼患者具有强化的结膜免疫反应,而干眼患者则表现出免疫反应,线粒体功能障碍和细胞完整性降低.

科学领域:

眼科医生眼科眼科
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

眼表面疾病 (OSD) 是局部青光眼药物的常见并发症,通常导致治疗不良.
了解绿眼和干眼疾病中OSD背后的分子机制对于改善患者的治疗结果至关重要.

研究的目的:

与健康对照人群相比,研究青光眼和干眼病患者的结结膜转录基因变异.
确定在这些患者群体中导致OSD的特定生物途径和基因失调.

主要方法:

使用印记细胞学从玻璃眼患者 (n=33),干眼患者 (n=9) 和健康对照组 (n=14) 获得了状结膜样本.
大量RNA测序和生物信息学分析,包括英才途径分析 (IPA),用于识别差异表达的基因和相关途径.
使用定量实时PCR (qRT-PCR) 来验证关键发现.

主要成果:

与对照组相比,青光眼患者表现出200个修饰基因,其中79%的改变途径与宿主防御机制有关.
干眼患者表现出233个差异表达的基因,其中包括宿主反应 (39%),细胞增殖/完整性 (15%) 和线粒体功能障碍 (16%).
在接受治疗的玻璃眼和干眼样本之间观察到大量的基因变异 (650个),表明了不同的分子谱.

结论:

玻璃眼患者表现出增强的结膜免疫反应,可能导致OSD并影响治疗坚持.
干眼疾病涉及免疫反应,线粒体功能障碍和结膜细胞完整性受损的复杂相互作用.
这些转录基因洞察力为新的治疗策略提供了潜在的目标,以管理绿眼和干眼患者的OSD.

关键词:

在RNA测序过程中,RNA测序青光眼药物治疗青光眼药物治疗印象细胞学印象细胞学眼睛表面疾病眼睛表面疾病

更多相关视频

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Establishment of A Mouse Model of Aqueous Deficiency Dry Eye

Published on: November 1, 2024

相关概念视频

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...